Phasecraft's 3,000-Emulation VQE Molecular Dataset With NVIDIA Was Computed on GPUs Under Wellcome Leap's Q4Bio: What the 14 September 2026 Announcement Shows
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
Phasecraft and NVIDIA announced on 14 September 2026 what Phasecraft calls the largest known database of Variational Quantum Eigensolver results for molecules, more than 3,000 emulations across thirteen molecular systems, computed on NVIDIA Hopper GPUs at the University of Nottingham. No quantum computer ran any of it, and the announcement says so in its own description of the method.
The dataset is an emulated VQE molecular dataset: for each of the 13 molecular systems, a classical GPU cluster worked out what a quantum processor of 4 to 32 qubits would return when asked for the lowest-energy state of the molecule, with most of the circuits in the 24-to-28-qubit range. Its purpose is to train Phasecraft's quantum-enhanced density functional theory method, a way of improving the standard workhorse of computational chemistry with data a quantum computer would produce. The Wellcome Leap Q4Bio program that paid for it asks whether new algorithms can deliver quantum advantage for health, and its prizes require a demonstration on a real quantum computer with more than 50 qubits. For a hospital buyer or a clinical pharmacologist the announcement describes training data for a chemistry method, produced on conventional hardware, with no named molecular systems, quantitative accuracy benchmarks or clinical results disclosed.
The Phasecraft release, datelined London and Toronto, gives four numbers: over 3,000 unique emulations, 13 molecular systems, a qubit range of 4 to 32 with "the vast majority in the 24–28 qubit regime", and "a 15x simulation speedup over prior results when modeling physical, many-body systems integral to biology and health applications". The GPUs were NVIDIA Hopper hardware hosted at the University of Nottingham, driven through NVIDIA's cuQuantum software kit. Ashley Montanaro, Phasecraft's co-founder and chief executive, is quoted on the need "to push the limits of today's most capable hardware, both conventional and quantum"; Sam Stanwyck, NVIDIA's director of quantum product, on shortening "the timeline" to useful quantum computing. The release describes the dataset as "a training foundation for quantum-enhanced molecular modeling, which could accelerate drug discovery at a scale previously out of reach, as quantum hardware develops". The conditional clause at the end carries the weight of the sentence.
The Minimal-Basis Run Gave T4-Lysozyme the Wrong Binding Sign: What Cleveland Clinic, RIKEN and IBM Changed to Correct It
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
On 9 September 2026 Cleveland Clinic announced that a team from Cleveland Clinic, the RIKEN Center for Computational Science and IBM had reached the finals of the 2026 ACM Gordon Bell Prize, for quantum-classical electronic-structure calculations on protein-ligand complexes of 11,608 and 12,635 atoms. Four days earlier the preprint behind that entry gained a second version, and buried in it is a result that deserves more attention than the atom count.
When the team computed the binding energy of a well-studied protein-ligand pair in a minimal basis set, the answer came out too positive, which is to say it pointed the wrong way for a ligand known to bind. Recomputing it with richer orbitals in the binding region and a tighter bath threshold together corrects the sign of the binding energy, at about ten times more in total node-hours. The revision also reports a first end-to-end wall-clock time, 62.4 hours from fragment generation to energy reconstruction, for a bound-complex ground-state run.
When the Error Check Happens Decides What It Buys
A 54 percent error cut, and what it was measured on
Simulating a molecule on a quantum computer means chopping its time evolution into many short slices, a technique called Trotterization. Accuracy improves as the slices get finer, and finer slices make a deeper circuit, and every additional gate in that circuit is another chance for a physical fault. Depth is what the chemistry asks for and depth is what today's hardware punishes, which is the bottleneck the field calls the deep Trotter dilemma.
A preprint from IonQ, qBraid and NVIDIA, posted in May 2026 by James Brown, Jason Iaconis, Yuri Alexeev and colleagues, reports that a combination of the Generalized Superfast Encoding, Clifford Noise Reduction and Shor-style stabilizer verification lowered the logical error rate by up to 54 percent on a trapped-ion machine. The encoding itself carries no such requirement, and Clifford Noise Reduction can be run with its stabilizer readout deferred; what the paper establishes is that the advantage over the unprotected baseline depended on mid-circuit measurement, the ability to read some qubits partway through a run, learn from them and continue with the rest.
What the number does and does not cover
The unprotected baseline is a six-qubit encoded Clifford Trotter step; the protected implementation that produced the 54 percent figure is wider, at 26 qubits and 580 gates, the extra width being the verification machinery itself. Both ran on a Barium development system similar to IonQ's forthcoming Tempo line. Clifford circuits are the well-behaved subset of quantum operations an ordinary laptop can simulate exactly, which is what makes them useful test articles: the correct answer is known in advance, so any deviation is measurable error. No molecule, binding energy or reaction barrier appears anywhere in the result, while IonQ's own account presents the same figure alongside the prospect of lower research costs and shorter time to market.
The control arm is the transferable finding
Keep the verification structure but move the stabilizer readout to the end of the circuit and it still beats having no error detection at all. What it stops doing is beating the unprotected baseline by a statistically significant margin for a single stabilizer round. Only the mid-circuit version clears that bar, which points at the timing of fault detection as the operative ingredient. For scale, published resource estimates for computing spin gaps in models of the cytochrome P450 catalytic cycle, a methodology benchmark and not a dosing or interaction predictor, run near 1,434 logical qubits and roughly 4.6 million physical qubits over 73 hours, on stated and assumption-dependent compilation figures. This Monitor records the work at TRL 3 on the simulation pillar.
Inside the 156-Qubit Enzyme Calculation
QC Ware reports a molecular calculation on quantum hardware
QC Ware says it calculated the electrostatic interaction energy of nitric oxide reductase by combining GPU-accelerated molecular modeling, classical chemistry methods, and quantum measurements on IBM's 156-qubit Heron processor. The enzyme is chemically demanding because its active region contains metal. The public announcement makes the electrostatic interaction energy calculation concrete, but it does not disclose the molecular partition, circuit design, measurement count, error mitigation, reference value, or final numerical error. The release therefore supports a precise statement: QC Ware reports that a medically relevant class of molecular calculation reached named quantum hardware. It does not yet show that the quantum step improved the result.
The architecture has a clear division of labor
The hybrid chemistry workflow combines Promethium, GPU-accelerated molecular modeling, classical chemistry methods, and quantum measurements. The release does not disclose how work was partitioned among them. IBM's published description of Heron and System Two provides useful architectural context: its quantum processors operate with classical runtime servers and methods that divide larger calculations. The QC Ware release is the source for the later 156-qubit hardware claim. It also says the demonstration is not currently an integrated Promethium product capability. That sentence prevents a hardware claim from being mistaken for a production service.
The missing benchmark defines the next milestone
The announcement reports no quantum advantage and offers no comparison against a strong classical workflow for the same chemical task. Qubit count cannot supply that missing result. A buyer would need comparative accuracy, resources, runtime, repeatability, and a decision consequence for chemists. The public record therefore places the work at TRL 3: a vendor-reported hardware proof of concept for one molecular property. Its product boundary is commercially informative because it separates an experimental module from the platform available today. The next persuasive record would show what the quantum measurements add at a fixed cost or error, and whether that contribution changes a research decision.